Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0016632 (
Fox
)
1,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A cDNA encoding mouse
deoxycytidine kinase
(
dCK
) (
EC 2.7.1.74
) was cloned from a mouse T-cell lambda ZAP cDNA library. An insert of 2.8 kilobases (kb) contained the entire coding sequence of 780 base pairs. The protein coding sequence was 88% homologous at the nucleotide level with human
dCK
cDNA (Chottiner, E. G., Shewach, D. S., Datta, N. S., Ashcraft, E., Gribbin, D., Ginsburg, D.,
Fox
, I. H., and Mitchell, B. S. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 1531-1535). At the amino acid level the homology was greater with only 16 of the 260 amino acids being different. Northern blot analyses revealed a size of 3.4 kb for mouse
dCK
mRNA as compared with 2.8 kb for human
dCK
. Part of the 3'-untranslated region was conserved between human and mouse
dCK
cDNA in contrast to the remainder of the 3'-sequence which was unrelated and about 500 nucleotides longer in mouse
dCK
cDNA. Mouse
dCK
cDNA showed cross-hybridization with several bands in EcoRI-digested genomic DNA from seven different mammalian species and chicken but not with yeast DNA. Both mouse and human
dCK
were cloned into the T5 promotor pQE30 vector system, expressed in Escherichia coli and purified to homogeneity. The kinetic constants for dCyd phosphorylation were similar for the human and mouse enzymes and also similar to what previously has been observed for
dCK
purified from human tissues. Mouse
dCK
was less efficient with regard to dAdo, dGuo, and ddCyd phosphorylation as compared with human
dCK
when using ATP as phosphate donor in a phosphoryl transfer assay.
...
PMID:2 cloning and expression of mouse deoxycytidine kinase. Pure recombinant mouse and human enzymes show differences in substrate specificity. 792 97